These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27216582)

  • 1. Underestimation of Variance of Predicted Health Utilities Derived from Multiattribute Utility Instruments.
    Chan KK; Xie F; Willan AR; Pullenayegum EM
    Med Decis Making; 2017 Apr; 37(3):262-272. PubMed ID: 27216582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility: A Bayesian Approach.
    Pullenayegum EM; Chan KK; Xie F
    Med Decis Making; 2016 Feb; 36(2):223-33. PubMed ID: 26139449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creating a Multiply Imputed Value Set for the EQ-5D-5L in Canada: State-Level Misspecification Terms Are Needed to Characterize Parameter Uncertainty Correctly.
    Tsui TCO; Chan KKW; Xie F; Pullenayegum EM
    Med Decis Making; 2024 May; 44(4):405-414. PubMed ID: 38591189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing Uncertainty in EQ-5D Value Sets: The Role of Spatial Correlation.
    Shams S; Pullenayegum E
    Med Decis Making; 2019 Feb; 39(2):91-99. PubMed ID: 30678526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capturing Valuation Study Sampling Uncertainty in the Estimation of Health State Utility Values Using the EQ-5D-3L.
    Poulimenos S; Round J; Baio G
    Med Decis Making; 2024 May; 44(4):393-404. PubMed ID: 38584481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size.
    Chan KKW; Xie F; Willan AR; Pullenayegum EM
    Med Decis Making; 2018 Jan; 38(1):26-33. PubMed ID: 28823185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.
    Kennedy-Martin M; Slaap B; Herdman M; van Reenen M; Kennedy-Martin T; Greiner W; Busschbach J; Boye KS
    Eur J Health Econ; 2020 Nov; 21(8):1245-1257. PubMed ID: 32514643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Bayesian Markov chain Monte Carlo methods to estimate EQ-5D utility scores from EORTC QLQ data in myeloma for use in cost-effectiveness analysis.
    Kharroubi SA; Edlin R; Meads D; Browne C; Brown J; McCabe C
    Med Decis Making; 2015 Apr; 35(3):351-60. PubMed ID: 25784746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the COPD Assessment Test onto EQ-5D.
    Hoyle CK; Tabberer M; Brooks J
    Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping between 6 Multiattribute Utility Instruments.
    Chen G; Khan MA; Iezzi A; Ratcliffe J; Richardson J
    Med Decis Making; 2016 Feb; 36(2):160-75. PubMed ID: 25840901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L.
    Lindkvist M; Feldman I
    Health Qual Life Outcomes; 2016 Sep; 14(1):134. PubMed ID: 27644119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Importance of Accounting for Parameter Uncertainty in SF-6D Value Sets and Its Impact on Studies that Use the SF-6D to Measure Health Utility.
    Kharroubi SA; Beyh Y; Abdul Fattah E; Young T
    Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32498412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the Beck Depression Inventory to the EQ-5D-3L in Patients with Depressive Disorders.
    Grochtdreis T; Brettschneider C; Hajek A; Schierz K; Hoyer J; Koenig HH
    J Ment Health Policy Econ; 2016 Jun; 19(2):79-89. PubMed ID: 27453455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly.
    Badia X; Trainer P; Biermasz NR; Tiemensma J; Carreño A; Roset M; Forsythe A; Webb SM
    J Med Econ; 2018 Apr; 21(4):382-389. PubMed ID: 29261359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-Analysis.
    Mohiuddin S; Payne K
    Med Decis Making; 2014 Jul; 34(5):666-85. PubMed ID: 24695961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework.
    Kharroubi SA; Beyh YS; Brazier J; Yang Y
    Qual Life Res; 2020 Jun; 29(6):1495-1507. PubMed ID: 32016681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease Areas.
    Richardson J; Iezzi A; Khan MA; Chen G; Maxwell A
    Med Decis Making; 2016 Feb; 36(2):147-59. PubMed ID: 26582319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can multi-attribute utility instruments adequately account for subjective well-being?
    Richardson J; Chen G; Khan MA; Iezzi A
    Med Decis Making; 2015 Apr; 35(3):292-304. PubMed ID: 25623064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D Multi-Attribute Utility Instruments in Patients Who Have Previously Undergone Bariatric Surgery.
    Campbell JA; Palmer AJ; Venn A; Sharman M; Otahal P; Neil A
    Patient; 2016 Aug; 9(4):311-22. PubMed ID: 26841910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.